Ireland· IE-PA-PA2261/006/001
Kwells 300 microgram Tablets
A scopolamine product containing hyoscine hydrobromide, registered in Ireland by Dexcel Pharma GmbH. The same ATC class is registered in 6 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Scopolamine is registered in 6 of 19 countries.
Countries holding a registration under ATC A04AD01 (scopolamine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Scopolamine · ATC A04AD01
6 / 19 countries
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
The record
At a glance
HPRA (Ireland)- Active substance
- Hyoscine hydrobromide
- Manufacturer
- Dexcel Pharma GmbH
- Country
- Ireland (IE)
- ATC code
- A04AD01
- ATC class
- Scopolamine
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2261/006/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for scopolamine.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Scopolamine · interactions on record
335 records
- 7 severe
- 197 moderate
- 17 minor
- 114 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DextropropoxypheneN02AC04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Scopolamine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHyoscine hydrobromide 300microgram tabletsNiche Pharma Ltd
- United StatesscopolamineActavis Pharma, Inc.
- FranceBROMHYDRATE DE SCOPOLAMINE RENAUDIN 0,025 %, solution injectableLABORATOIRE RENAUDIN
- BelgiumBromhydrate de Scopolamine 0,25 mg/mlLaboratoires Sterop
- FinlandOftan-ScopolaminSanten Oy
- CanadaSCOPOLAMINE HYDROBROMIDE INJECTIONOMEGA LABORATORIES LIMITED
- NorwayScopodermBaxter Medical AB
- GermanyBoro-Scopol NOmnivision Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Scopolamine Hbr Sterop
- Germany · Boro-Scopol N, Scopoderm Tts
- Denmark · Scopoderm
- Spain · Escopolamina B. Braun
- Finland · Scopoderm
- France · Bromhydrate De Scopolamine Renaudin, Scopoderm Tts
- United Kingdom (Northern Ireland) · Hyoscine Hydrobromide Wockhardt Uk, Hyoscine Martindale Pharma
- Iceland · Scopoderm
- Luxembourg · Scopoderm Tts
- Malta · Kwells
- Netherlands · Scopoderm
- Norway · Scopoderm
- Sweden · Scopoderm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d75da5c2-fdc2-4daa-93ed-e2e2142b04d9 GET /v1/drugs/d75da5c2-fdc2-4daa-93ed-e2e2142b04d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A04AD",
"A04AD01"
],
"strength": null,
"pa_number": "PA2261/006/001",
"substances": [
"Hyoscine hydrobromide"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "01/04/1979",
"dispensing_status": "Product not subject to medical prescription",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about scopolamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.